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Introduction 
Bone marrow-derived mesenchymal stem cells (BM-MSC) are a potential 
therapeutic tool due to their ability for migrating and producing neuroprotector 
factors when they are transplanted in other neurodegenerative diseases. 
Moreover, some investigations have shown that BM-MSC are able to modulate 
astrocyte activation and neuroprotector factor production. The aim of this study 
was to evaluate the long-time effects of a BM-MSC experimental therapy in the 
hyh mouse model of congenital hydrocephalus. 
 
Methods 
BM-MSC were characterized in vitro and then transplanted into the ventricles of 
young hydrocephalic hyh mice, before they develop the severe hydrocephalus. 
Non-hydrocephalic normal mice (wt) and hydrocephalic hyh mice sham-injected 
(sterile saline serum) were used as controls. Samples were studied by 
analyzing and comparing mRNA, protein level expressions and immunoreaction 
related with the progression and severity of hydrocephalus. 
 
Results 
Fourteen days after transplantation, hydrocephalic hyh mice with BM-MSC 
showed lower ventriculomegaly. In these animals, BM-MSC were found 
undifferentiated and spread into the periventricular astrocyte reaction. There, 
BM-MSC were detected producing several neuroprotector factors (BDNF, 
GDNF, NGF, VEGF), in the same way as reactive astrocytes. Total neocortical 
levels of NGF, TGF-β and VEGF were found increased in hydrocephalic hyh 
mice transplanted with BM-MSC. Furthermore, astrocytes showed increased 
expressions of aquaporin-4 (water channel protein) and Slit-2 (neuroprotective 
and anti-inflammatory molecule). 
 
Conclusions 
BM-MSC seem to lead to recovery of the severe neurodegenerative conditions 
associated to congenital hydrocephalus mediated by reactive astrocytes. 
 
 
